# Life Extension **Domain:** medicine **Doc Type:** Concept Node **Classification:** Infrastructure Concept **Maturity:** Evolving **Related:** [[Nonlinear Dynamics]], [[Human Agency]], [[Governance Testbeds]], [[Meritocratic Risk Pricing]], [[Measurement Capacity]] --- ## Definition **Biological interventions extending human lifespan beyond current natural limits**, including senescence prevention, disease elimination, and rejuvenation therapies. Life extension differs from life expectancy improvement (preventing premature death) by extending potential lifespan. --- ## General Context Gerontology research demonstrates that aging is mutable—caloric restriction, genetic interventions, and drug therapies extend lifespan in model organisms. Human trials of longevity interventions are expanding with increasing pharmaceutical investment. --- ## Governance Context [[articles/Climate Systems as Human Resilience Platforms|Post-electoral resilience systems]] must account for [[wiki/Life Extension|life extension]] trajectories in [[wiki/Logistics Optimization|resource allocation models]], with [[wiki/Meritocratic Risk Pricing|risk-adjusted pricing]] incorporating longevity uncertainty and [[wiki/Measurement Capacity|lifespan outcome measurement]]. --- ## Key Insight Life extension success creates novel governance challenges: intergenerational equity (should resource allocation shift toward longer-living cohorts?), access inequality (expensive interventions available only to wealthy), and psychological adaptation. --- ## See Also [[Climate Systems as Human Resilience Platforms]], [[How Reparative Justice Became Meritocracy]], [[Human Ecology]], [[Model-Based Governance]], [[Paradigm Shift]]